Medication at follow-up
| Variable | BMI (kg/m2) | ||||
| Total (n=6297) | 18.5–24.9 (n=2095) | 25–29.9 (n=2956) | >30 (n=1246) | p Value | |
| Medication, n (%) | |||||
| Aspirin | 5352 (85) | 1366 (85) | 2014 (85) | 825 (86) | 0.979 |
| β blocker | 5038 (80) | 1246 (78) | 1883 (80) | 832 (86) | <0.001 |
| Statin | 5793 (92) | 1451 (91) | 2163 (92) | 898 (93) | 0.092 |
| ACE inhibitor | 3149 (50) | 775 (48) | 1154 (49) | 547 (57) | <0.001 |
| Optimal medication*, n (%) | 4975 (79) | 1219 (76) | 1839 (78) | 818 (85) | <0.001 |
↵* Defined as the use of three or more of the four types of medication.
BMI, body mass index.